134 related articles for article (PubMed ID: 36961616)
21. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
Park SY; Kim CK; Park BK; Kwon GY
AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
[TBL] [Abstract][Full Text] [Related]
22. Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer.
Nagayama M; Watanabe Y; Terai A; Araki T; Notohara K; Okumura A; Amoh Y; Ishimori T; Nakashita S; Dodo Y
Jpn J Radiol; 2011 Aug; 29(7):488-94. PubMed ID: 21882091
[TBL] [Abstract][Full Text] [Related]
23. Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions.
Polanec SH; Helbich TH; Bickel H; Wengert GJ; Pinker K; Spick C; Clauser P; Susani M; Shariat S; Baltzer PAT
Invest Radiol; 2018 Dec; 53(12):736-741. PubMed ID: 29985792
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones.
Gaudiano C; Bianchi L; Corcioni B; Giunchi F; Schiavina R; Ciccarese F; Braccischi L; Rustici A; Fiorentino M; Brunocilla E; Golfieri R
Int Urol Nephrol; 2022 Feb; 54(2):263-271. PubMed ID: 34822065
[TBL] [Abstract][Full Text] [Related]
25. Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy.
Quentin M; Schimmöller L; Arsov C; Rabenalt R; Antoch G; Albers P; Blondin D
Eur Radiol; 2014 Jan; 24(1):209-13. PubMed ID: 23995881
[TBL] [Abstract][Full Text] [Related]
26. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?
Turkbey B; Shah VP; Pang Y; Bernardo M; Xu S; Kruecker J; Locklin J; Baccala AA; Rastinehad AR; Merino MJ; Shih JH; Wood BJ; Pinto PA; Choyke PL
Radiology; 2011 Feb; 258(2):488-95. PubMed ID: 21177390
[TBL] [Abstract][Full Text] [Related]
27. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
28. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
Woo S; Kim SY; Cho JY; Kim SH
AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
[TBL] [Abstract][Full Text] [Related]
31. How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy?
Song G; Ruan M; Wang H; Fan Y; He Q; Lin Z; Li X; Li P; Wang X; He Z; Zhou L
J Urol; 2020 Dec; 204(6):1202-1208. PubMed ID: 32716686
[TBL] [Abstract][Full Text] [Related]
32. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
[TBL] [Abstract][Full Text] [Related]
33. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L
J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694
[TBL] [Abstract][Full Text] [Related]
34. Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer.
Moraes MO; Roman DHH; Copetti J; de S Santos F; Agra A; Noronha JAP; Carvalhal G; Neto EJD; Zanon M; Baldisserotto M; Hochhegger B
World J Urol; 2020 Apr; 38(4):981-991. PubMed ID: 31175458
[TBL] [Abstract][Full Text] [Related]
35. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
[TBL] [Abstract][Full Text] [Related]
36. Time-Dependent Diffusion in Prostate Cancer.
Lemberskiy G; Rosenkrantz AB; Veraart J; Taneja SS; Novikov DS; Fieremans E
Invest Radiol; 2017 Jul; 52(7):405-411. PubMed ID: 28187006
[TBL] [Abstract][Full Text] [Related]
37. Prostate Cancer Diffusion-Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion-Weighting Level Matter?
Maier SE; Wallström J; Langkilde F; Johansson J; Kuczera S; Hugosson J; Hellström M
J Magn Reson Imaging; 2022 Mar; 55(3):842-853. PubMed ID: 34535940
[TBL] [Abstract][Full Text] [Related]
38. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
39. The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.
Zattoni F; Marra G; Kasivisvanathan V; Grummet J; Nandurkar R; Ploussard G; Olivier J; Chiu PK; Valerio M; Gontero P; Guo H; Zhuang J; Barletta F; Leni R; Frydenberg M; Moon D; Hanegbi U; Landaumailto A; Snow R; Apfelbeck M; Kretschmer A; van den Bergh R; Novara G; Briganti A; Dal Moro F; Gandaglia G
J Urol; 2022 Oct; 208(4):830-837. PubMed ID: 36082555
[TBL] [Abstract][Full Text] [Related]
40. Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer.
Hassanzadeh E; Alessandrino F; Olubiyi OI; Glazer DI; Mulkern RV; Fedorov A; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2018 May; 43(5):1237-1244. PubMed ID: 28840280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
